Last reviewed · How we verify
Multidrug resistant HIV-1 infection
Approved treatments
- Sunlenca · Gilead Sciences
Sunlenca works by binding to a specific site on the HIV-1 protease, preventing the virus from replicating.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Multidrug resistant HIV-1 infection patent landscape — cliff calendar, originator estates, attackable patents
- Multidrug resistant HIV-1 infection treatment landscape brief
- Multidrug resistant HIV-1 infection treatment updates RSS
Frequently asked questions about Multidrug resistant HIV-1 infection
What drugs treat Multidrug resistant HIV-1 infection?
Tracked treatments include Sunlenca.
What is the treatment for Multidrug resistant HIV-1 infection?
Standard treatment for Multidrug resistant HIV-1 infection includes Sunlenca. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Multidrug resistant HIV-1 infection patent cliff · Multidrug resistant HIV-1 infection CI report
- Treatment: Sunlenca · Gilead Sciences
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing